Status:
COMPLETED
A Transtheoretical Model Group Therapy for Cocaine
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborating Sponsors:
The University of Texas Health Science Center, Houston
Conditions:
Cocaine Use Disorders
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to determine the feasibility and promise of a recently manualized group therapy based on the Transtheoretical Model for cocaine use disorders.
Detailed Description
Cocaine use in the general population is a significant and costly problem. Novel and innovative interventions targeting cocaine abuse are needed. The Transtheoretical Model of behavior change (TTM) of...
Eligibility Criteria
Inclusion
- Male and female adults (ages 18-65 years old), of any race, who meet DSM-IV criteria for cocaine abuse or dependence disorder will be recruited. In addition, eligible participants must be:
- (1) judged to be in generally good physical and psychiatric health except for possible acute drug related problems;
- (2) willing and able to participate in the 6-week, group outpatient treatment;
- (3) able to provide the name of at least one person who can generally locate their whereabouts; and
- (4) willing to be followed for 3 months after treatment ends.
- Potential subjects with simple drug charges whose legal contacts are willing to forego data revelation will be included. Although cocaine dependence will be the primary drug for which patients are seeking treatment, we will not exclude participants who are abusing additional substances.
Exclusion
- Individuals will be ineligible for study participation based on the following criteria:
- (1) current diagnosis of an Axis I psychiatric disorder other than cocaine dependence;
- (2) current psychiatric symptoms requiring medication;
- (3) severe medical, cognitive and /or psychiatric impairment that precludes cooperation with study protocol;
- (4) substance withdrawal symptoms requiring medical attention;
- (5) currently receiving other psychosocial therapy for substance abuse with the exception of AA, NA or CA;
- (6) impending incarceration;
- (7) inability to read, write, speak English;
- (8) inability or unwillingness to participate in the 6-week, group outpatient treatment (e.g., halfway house or other aftercare program restrictions).
Key Trial Info
Start Date :
October 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2007
Estimated Enrollment :
138 Patients enrolled
Trial Details
Trial ID
NCT00178776
Start Date
October 1 2003
End Date
June 1 2007
Last Update
January 11 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas Houston Mental Sciences Institute
Houston, Texas, United States, 77030